IT8003429A0 - Derivati imidazo-rifamicinici metodi per la loro preparazione e loro uso come sostanza ad azione antibatterica - Google Patents

Derivati imidazo-rifamicinici metodi per la loro preparazione e loro uso come sostanza ad azione antibatterica

Info

Publication number
IT8003429A0
IT8003429A0 IT8003429A IT342980A IT8003429A0 IT 8003429 A0 IT8003429 A0 IT 8003429A0 IT 8003429 A IT8003429 A IT 8003429A IT 342980 A IT342980 A IT 342980A IT 8003429 A0 IT8003429 A0 IT 8003429A0
Authority
IT
Italy
Prior art keywords
riphamic
imidazo
substance
preparation
antibacterial action
Prior art date
Application number
IT8003429A
Other languages
English (en)
Other versions
IT1154655B (it
Inventor
Egidio Marchi Lauret Montecchi
Original Assignee
Alfa Farmaceutici Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Farmaceutici Spa filed Critical Alfa Farmaceutici Spa
Publication of IT8003429A0 publication Critical patent/IT8003429A0/it
Priority to IT03429/80A priority Critical patent/IT1154655B/it
Priority to NLAANVRAGE8102290,A priority patent/NL187022C/xx
Priority to US06/262,123 priority patent/US4341785A/en
Priority to AU70655/81A priority patent/AU537093B2/en
Priority to AT0222781A priority patent/AT373599B/de
Priority to LU83376A priority patent/LU83376A1/fr
Priority to GR65010A priority patent/GR75640B/el
Priority to PH25656A priority patent/PH17207A/en
Priority to FR8110058A priority patent/FR2482967A1/fr
Priority to PT73064A priority patent/PT73064B/pt
Priority to EG280/81A priority patent/EG14891A/xx
Priority to NO811731A priority patent/NO155622C/no
Priority to DK224781A priority patent/DK157876C/da
Priority to ES502906A priority patent/ES502906A0/es
Priority to IE1139/81A priority patent/IE51204B1/en
Priority to BE2/59169A priority patent/BE888895A/fr
Priority to FI811565A priority patent/FI69467C/fi
Priority to ZA00813430A priority patent/ZA813430B/xx
Priority to CA000378015A priority patent/CA1142518A/en
Priority to SE8103216A priority patent/SE453089B/sv
Priority to GB8115790A priority patent/GB2079270B/en
Priority to CH3381/81A priority patent/CH648037A5/de
Priority to DE19813120460 priority patent/DE3120460A1/de
Priority to JP7787781A priority patent/JPS5711987A/ja
Priority to AR285424A priority patent/AR226212A1/es
Priority to PH26842A priority patent/PH18704A/en
Application granted granted Critical
Publication of IT1154655B publication Critical patent/IT1154655B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IT03429/80A 1980-05-22 1980-05-22 Derivati imidazo-rifamicinici metodi per la loro preparazione e loro uso come sostanza ad azione antibatterica IT1154655B (it)

Priority Applications (26)

Application Number Priority Date Filing Date Title
IT03429/80A IT1154655B (it) 1980-05-22 1980-05-22 Derivati imidazo-rifamicinici metodi per la loro preparazione e loro uso come sostanza ad azione antibatterica
NLAANVRAGE8102290,A NL187022C (nl) 1980-05-22 1981-05-11 Rifamycine derivaten met anti-bacteriele werking, en dergelijke derivaten bevattend farmaceutisch preparaat.
US06/262,123 US4341785A (en) 1980-05-22 1981-05-11 Imidazo-rifamycin derivatives with antibacterial utility
AU70655/81A AU537093B2 (en) 1980-05-22 1981-05-18 New imidazo-rifamycin derivatives with antibacterial utility
AT0222781A AT373599B (de) 1980-05-22 1981-05-19 Verfahren zur herstellung neuer rifamycinderivate
LU83376A LU83376A1 (fr) 1980-05-22 1981-05-20 Nouveaux derives d'imidazo-rifamycine a activite antibacterienne
GR65010A GR75640B (it) 1980-05-22 1981-05-20
PH25656A PH17207A (en) 1980-05-22 1981-05-20 New imidazo-rifamycin derivatives with antibacterial utility
FR8110058A FR2482967A1 (fr) 1980-05-22 1981-05-20 Nouveaux derives de l'imidazo-rifamycine, leur procede de preparation et leur application en therapeutique
PT73064A PT73064B (en) 1980-05-22 1981-05-20 New imidazo-rifamycin derivatives with anti-bacterial utility
EG280/81A EG14891A (en) 1980-05-22 1981-05-20 A process for preparation of derivatives of imiadozo-new rifamicyn have process antibacterial utility
DK224781A DK157876C (da) 1980-05-22 1981-05-21 Analogifremgangsmaade til fremstilling af imidazo-rifamycin-derivater
NO811731A NO155622C (no) 1980-05-22 1981-05-21 Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrido- og isokinolin (1[,2[:1,2) imidazo (5,4-c) rifamycin sv og s derivater.
ES502906A ES502906A0 (es) 1980-05-22 1981-05-21 Un procedimiento para la preparacion de nuevos derivados de imidazo-rifamicina
IE1139/81A IE51204B1 (en) 1980-05-22 1981-05-21 Imidazo-rifamycin derivatives
BE2/59169A BE888895A (fr) 1980-05-22 1981-05-21 Nouveaux derives d'imidazo-rifamycine a activite antibacterienne
FI811565A FI69467C (fi) 1980-05-22 1981-05-21 Foerfarande foer framstaellning av nya terapeutiskt anvaendbara pyrido- och isokinolin(1',2':1,2)imidazo(5,4-c)rifamycin soch sv-derivat
ZA00813430A ZA813430B (en) 1980-05-22 1981-05-21 New imidazo-rifamycin derivatives with antibacterial utility
CA000378015A CA1142518A (en) 1980-05-22 1981-05-21 Imidazo-rifamycin derivatives with antibacterial utility
SE8103216A SE453089B (sv) 1980-05-22 1981-05-21 Imidazo-rifamycinderivat, forfarande for framstellning derav och farmaceutisk komposition
GB8115790A GB2079270B (en) 1980-05-22 1981-05-22 Imidazo-rifamycin derivatives
CH3381/81A CH648037A5 (de) 1980-05-22 1981-05-22 Imidazo-rifamycin-derivate mit antibakterieller wirksamkeit.
DE19813120460 DE3120460A1 (de) 1980-05-22 1981-05-22 Pyridoimidazolorifamycinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
JP7787781A JPS5711987A (en) 1980-05-22 1981-05-22 Novel imidazo-rifamycin derivative
AR285424A AR226212A1 (es) 1980-05-22 1981-05-22 Procedimiento para preparar nuevos derivados de imidazo rifamicina
PH26842A PH18704A (en) 1980-05-22 1982-02-09 Method of treatment using inidazo-rifamycin derivatives with antibacterial utility

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT03429/80A IT1154655B (it) 1980-05-22 1980-05-22 Derivati imidazo-rifamicinici metodi per la loro preparazione e loro uso come sostanza ad azione antibatterica

Publications (2)

Publication Number Publication Date
IT8003429A0 true IT8003429A0 (it) 1980-05-22
IT1154655B IT1154655B (it) 1987-01-21

Family

ID=11107198

Family Applications (1)

Application Number Title Priority Date Filing Date
IT03429/80A IT1154655B (it) 1980-05-22 1980-05-22 Derivati imidazo-rifamicinici metodi per la loro preparazione e loro uso come sostanza ad azione antibatterica

Country Status (25)

Country Link
US (1) US4341785A (it)
JP (1) JPS5711987A (it)
AR (1) AR226212A1 (it)
AT (1) AT373599B (it)
AU (1) AU537093B2 (it)
BE (1) BE888895A (it)
CA (1) CA1142518A (it)
CH (1) CH648037A5 (it)
DE (1) DE3120460A1 (it)
DK (1) DK157876C (it)
EG (1) EG14891A (it)
ES (1) ES502906A0 (it)
FI (1) FI69467C (it)
FR (1) FR2482967A1 (it)
GB (1) GB2079270B (it)
GR (1) GR75640B (it)
IE (1) IE51204B1 (it)
IT (1) IT1154655B (it)
LU (1) LU83376A1 (it)
NL (1) NL187022C (it)
NO (1) NO155622C (it)
PH (2) PH17207A (it)
PT (1) PT73064B (it)
SE (1) SE453089B (it)
ZA (1) ZA813430B (it)

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1199374B (it) * 1984-05-15 1988-12-30 Alfa Farmaceutici Spa Processo per la preparazione di pirido-imidazo-rifamicine
IT1264494B1 (it) * 1993-03-23 1996-09-24 Alfa Wassermann Spa Uso di rifaximin e di formulazioni che la contengono nel trattamento delle dispepsie gastriche originate da helicobacter
US6861053B1 (en) * 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
US7048906B2 (en) 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
US5981522A (en) * 1995-09-01 1999-11-09 Kaneka Corporation Treatment of disease caused by infection of Helicobacter
KR100407851B1 (ko) * 1997-02-28 2004-04-29 가네가후치 가가쿠고교 가부시키가이샤 헬리코박터의감염에기인하는질환치료제
WO2003045319A2 (en) * 2001-11-21 2003-06-05 Activbiotics, Inc. Targeted therapeutics and uses thereof
WO2003051299A2 (en) * 2001-12-13 2003-06-26 Activbiotics, Inc. Sulfhydryl rifamycins and uses thereof
AU2003276254A1 (en) * 2002-11-05 2004-06-07 Piero Chiarelli Controlled and continued delivery of rifaximin and/or other substances
US7820652B2 (en) * 2003-09-24 2010-10-26 Activbiotics Pharma, Llc Regimen for the administration of rifamycin-class antibiotics
ITMI20032144A1 (it) * 2003-11-07 2005-05-08 Alfa Wassermann Spa Forme polimorfe di rifaximina, processi per ottenerle e
US7923553B2 (en) * 2003-11-07 2011-04-12 Alfa Wassermann, S.P.A. Processes for the production of polymorphic forms of rifaximin
US7902206B2 (en) * 2003-11-07 2011-03-08 Alfa Wassermann, S.P.A. Polymorphic forms α, β and γ of rifaximin
US20080262024A1 (en) * 2003-11-07 2008-10-23 Giuseppe Claudio Viscomi Rifaximin compositions and method of use
US7906542B2 (en) * 2004-11-04 2011-03-15 Alfa Wassermann, S.P.A. Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin
US7256187B2 (en) * 2004-03-10 2007-08-14 Cumbre Pharmaceuticals Inc. Rifamycin C-11 oxime derivatives effective against drug-resistant microbes
US7265107B2 (en) * 2004-03-10 2007-09-04 Cumbre Pharmaceuticals Inc. Rifamycin C-11 oxime cyclo derivatives effective against drug-resistant microbes
US7202246B2 (en) * 2004-06-09 2007-04-10 Cumbre Pharmaceuticals Inc. Spiro-rifamycin derivatives targeting RNA polymerase
US20060210492A1 (en) * 2005-03-02 2006-09-21 Kodsi Robert E Use of rifaximin for treatment and prevention of periodontal conditions
US20060210483A1 (en) * 2005-03-02 2006-09-21 Kodsi Robert E Non-systemic antibiotic formulations and related method of use and treatment of upper respiratory infections
US8003118B2 (en) * 2005-03-02 2011-08-23 Kodsi Robert E Use of rifaximin for the prevention of aspiration pneumonia and/or sepsis
SI1698630T1 (sl) 2005-03-03 2015-01-30 Alfa Wassermann S.P.A. Nove polimorfne oblike rifaksimina, postopki za njihovo pripravo in njihova uporaba v medicinskih pripravkih
ITBO20050123A1 (it) * 2005-03-07 2005-06-06 Alfa Wassermann Spa Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
CN101282981B (zh) 2005-08-11 2012-09-26 塔甘塔治疗公司 膦酸化利福霉素及其在预防和治疗骨和关节感染中的用途
CN101594885B (zh) 2006-03-09 2017-07-18 萨利克斯药品公司 利福昔明抗直肠功能障碍制剂
PT2054066E (pt) 2006-08-02 2015-07-16 Salix Pharmaceuticals Inc Métodos para tratamento de enterite por radiação
ITMI20061692A1 (it) 2006-09-05 2008-03-06 Alfa Wassermann Spa Uso di polioli per ottenere forme polimorfe stabili di rifaximina
KR101667534B1 (ko) * 2006-09-22 2016-10-19 씨아이피엘에이 엘티디. 리팍시민
US20080161337A1 (en) * 2007-01-03 2008-07-03 Leonard Weinstock Use of Rifaximin for the Treatment of Chronic Prostatitis
US20080159987A1 (en) * 2007-01-03 2008-07-03 Leonard Weinstock Use of Rifaximin for the Treatment of Restless Legs Syndrome
ITMI20071241A1 (it) * 2007-06-20 2008-12-21 Solmag S P A Processo per la preparazione di rifaximina amorfa e rifaximina amorfa cosi' ottenuta
ES2905795T3 (es) 2007-07-06 2022-04-12 Lupin Ltd Composiciones farmacéuticas de rifaximina
WO2009008005A1 (en) 2007-07-06 2009-01-15 Lupin Limited Pharmaceutical compositions of rifaximin
US7709634B2 (en) * 2007-09-20 2010-05-04 Apotex Pharmachem Inc. Amorphous form of rifaximin and processes for its preparation
US8486956B2 (en) 2008-02-25 2013-07-16 Salix Pharmaceuticals, Ltd Forms of rifaximin and uses thereof
UA101829C2 (uk) 2008-02-25 2013-05-13 Саликс Фармасьютикалз, Лтд. ФОРМА η РИФАКСИМІНУ І ЇЇ ЗАСТОСУВАННЯ В ТЕРАПЕВТИЧНІЙ ПРАКТИЦІ
EP2252148B1 (en) 2008-02-26 2019-03-20 Salix Pharmaceuticals, Ltd. Methods for treating irritable bowel syndrome
US11779571B2 (en) 2008-02-26 2023-10-10 Salix Pharmaceuticals, Inc. Methods for treating irritable bowel syndrome (IBS)
WO2009137672A1 (en) 2008-05-07 2009-11-12 Salix Pharmaceuticals, Ltd. Methods of treating bowel disease by administering a bowel cleanser and an antibiotic
WO2010019511A2 (en) 2008-08-13 2010-02-18 Targanta Therapeutics Corp. Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections
RU2011116400A (ru) 2008-09-26 2012-11-10 Аска Фармасьютикал Ко., Лтд. (Jp) Средство для предотвращения и/или лечения функционального расстройства желудочно-кишечного тракта
ES2770308T3 (es) 2008-10-02 2020-07-01 Salix Pharmaceuticals Ltd Procedimientos de tratamiento de encefalopatía hepática
JP5756020B2 (ja) 2008-12-10 2015-07-29 シプラ・リミテッド リファキシミン複合体
IT1397617B1 (it) * 2009-04-20 2013-01-18 Alfa Wassermann Spa Nuovi derivati della rifamicina
NZ596851A (en) 2009-06-02 2013-10-25 Salix Pharmaceuticals Ltd Methods of treating hepatic encephalopathy
EP2475392A4 (en) 2009-09-13 2013-01-09 Salix Pharmaceuticals Ltd METHOD FOR TREATING IRRITATION SYNDROME
CN113274355B (zh) 2009-10-27 2023-05-30 鲁平有限公司 利福昔明固体分散体
RU2012126084A (ru) 2009-11-23 2013-12-27 Сипла Лимитед Пенная композиция для местного применения
WO2011080691A1 (en) 2009-12-28 2011-07-07 Silvio Massimo Lavagna Method for the production of amorphous rifaximin
EP3650022A1 (en) 2010-02-18 2020-05-13 Salix Pharmaceuticals, Ltd. Methods for treating rifampin resistant clostridium difficilis infections
IT1398550B1 (it) 2010-03-05 2013-03-01 Alfa Wassermann Spa Formulazioni comprendenti rifaximina utili per ottenere un effetto prolungato nel tempo
JP6092629B2 (ja) 2010-03-10 2017-03-08 ルピン・リミテッドＬｕｐｉｎ Ｌｉｍｉｔｅｄ リファキシミン使用準備済懸濁液
EP2593463B1 (en) 2010-07-12 2020-05-06 Salix Pharmaceuticals, Inc. Formulations of rifaximin and uses thereof
WO2012035544A2 (en) 2010-09-13 2012-03-22 Sequent Scientific Ltd. A novel polymorphic form of rifaximin and process for its preparation
SG192122A1 (en) 2011-02-11 2013-08-30 Salix Pharmaceuticals Ltd Forms of rifaximin and uses thereof
CA2834829A1 (en) 2011-05-02 2012-11-08 Ranbaxy Laboratories Limited Rifaximin dimethylformamide solvate
ITMI20110890A1 (it) * 2011-05-19 2012-11-20 A M S A Anonima Materie Sint & Affini S P A Polimorfo di rifaximina e processo per la sua preparazione
ITBO20110461A1 (it) 2011-07-29 2013-01-30 Alfa Wassermann Spa Composizioni farmaceutiche comprendenti rifaximina, processi per la loro preparazione e loro uso nel trattamento di infezioni vaginali.
RU2496475C2 (ru) 2011-10-26 2013-10-27 Александр Васильевич Иващенко Фармацевтическая композиция и набор для лечения бактериальных инфекций
PL2773205T3 (pl) 2011-11-02 2024-09-02 Salix Pharmaceuticals, Inc. Ryfaksymina w leczeniu ustępującej biegunki z przewagą zespołu jelita drażliwego
EP2807148A4 (en) * 2012-01-25 2015-04-08 Salix Pharmaceuticals Ltd RIFAXIMIN DERIVATIVE AND USES THEREOF
ITBO20120368A1 (it) 2012-07-06 2014-01-07 Alfa Wassermann Spa Composizioni comprendenti rifaximina e amminoacidi, cristalli di rifaximina derivanti da tali composizioni e loro uso.
WO2014091432A1 (en) 2012-12-12 2014-06-19 Ranbaxy Laboratories Limited Pharmaceutical compositions of rifaximin
EP2968283A1 (en) 2013-03-15 2016-01-20 ALFA WASSERMANN S.p.A. Rifaximin for use in the treating of vaginal infections.
JP2016516988A (ja) 2013-03-15 2016-06-09 アルファ ワッセルマン ソシエタ ペル アチオニＡｌｆａ Ｗａｓｓｅｒｍａｎｎ Ｓ．Ｐ．Ａ． 膣感染症を診断するための方法
NZ713440A (en) 2013-04-12 2019-02-22 Alfasigma Spa Nsaid administration and related compositions, methods and systems.
US9018225B1 (en) 2013-07-26 2015-04-28 Novel Laboratories Rifaximin crystalline forms and methods of preparation thereof
ES2621557T3 (es) 2014-03-31 2017-07-04 Euticals S.P.A. Mezcla polimórfica de rifaximina y su uso para la preparación de formulaciones sólidas
CA2946101A1 (en) * 2014-04-19 2015-10-22 Granules India Limited An improved process for the preparation of rifamycin derivatives
JP6693946B2 (ja) 2014-05-04 2020-05-13 サリックス ファーマスーティカルズ，インコーポレーテッド Ｉｂｓ微生物叢及びその使用
PL3546464T3 (pl) 2014-05-12 2020-11-02 Alfasigma S.P.A. Sposób wytwarzania i zastosowanie postaci krystalicznej Tau rifaksyminy solwatowanej z DEGME
EP2982764A1 (en) 2014-08-05 2016-02-10 ALFA WASSERMANN S.p.A. Identification of vaginal bacteria
US9988398B2 (en) 2016-06-07 2018-06-05 Cadila Healthcare Limited Crystalline form of rifaximin and process for its preparation
CN110072525B (zh) 2016-09-30 2022-12-02 萨利克斯药品公司 利福昔明的固态分散形式
CN110770244A (zh) * 2017-06-26 2020-02-07 倍尔福股份公司 吡啶并咪唑利福霉素衍生物的抗菌剂
IT201700091912A1 (it) * 2017-08-08 2019-02-08 Biofer Spa Nuove pirido-imidazo rifamicine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE273377C (it) *
AT273377B (de) * 1967-03-01 1969-08-11 Lepetit Spa Verfahren zur Herstellung von neuen Rifamycinen
AT344898B (de) * 1975-06-13 1978-08-10 Archifar Ind Chim Trentino Verfahren zur herstellung neuer rifamycin-verbindungen
DK345977A (da) * 1976-09-30 1978-03-31 Archifar Ind Chim Trentino G rifamycinforbindelser og fremgangsmaade til deres fremstillin
CH629212A5 (it) * 1976-10-18 1982-04-15 Erba Farmitalia Procedimento per la preparazione di composti di rifamicina.
CH633014A5 (en) * 1978-06-09 1982-11-15 Erba Farmitalia Rifamycin compounds

Also Published As

Publication number Publication date
FI69467C (fi) 1986-02-10
CA1142518A (en) 1983-03-08
DE3120460C2 (it) 1990-12-13
DE3120460A1 (de) 1982-03-11
FR2482967A1 (fr) 1981-11-27
AT373599B (de) 1984-02-10
PT73064B (en) 1982-07-05
SE8103216L (sv) 1981-11-23
DK157876B (da) 1990-02-26
IE811139L (en) 1981-11-22
CH648037A5 (de) 1985-02-28
NL187022B (nl) 1990-12-03
ZA813430B (en) 1982-06-30
IT1154655B (it) 1987-01-21
DK157876C (da) 1990-07-30
FI811565L (fi) 1981-11-23
NO155622C (no) 1987-04-29
PH17207A (en) 1984-06-19
IE51204B1 (en) 1986-10-29
FI69467B (fi) 1985-10-31
AR226212A1 (es) 1982-06-15
LU83376A1 (fr) 1981-09-11
DK224781A (da) 1981-11-23
NO811731L (no) 1981-11-23
JPS5711987A (en) 1982-01-21
GB2079270B (en) 1984-01-18
US4341785A (en) 1982-07-27
NL187022C (nl) 1991-05-01
AU537093B2 (en) 1984-06-07
BE888895A (fr) 1981-09-16
PH18704A (en) 1985-09-05
NO155622B (no) 1987-01-19
PT73064A (en) 1981-06-01
ES8203388A1 (es) 1982-04-01
SE453089B (sv) 1988-01-11
ES502906A0 (es) 1982-04-01
JPS6123192B2 (it) 1986-06-04
FR2482967B1 (it) 1985-03-29
EG14891A (en) 1985-12-31
NL8102290A (nl) 1981-12-16
GB2079270A (en) 1982-01-20
AU7065581A (en) 1981-11-26
ATA222781A (de) 1983-06-15
GR75640B (it) 1984-08-02

Similar Documents

Publication Publication Date Title
IT8003429A0 (it) Derivati imidazo-rifamicinici metodi per la loro preparazione e loro uso come sostanza ad azione antibatterica
IT1141057B (it) Derivati di deformiltilosina e loro preparazione
IT8222769A0 (it) Composti tetrakisazo derivati e procedimenti per la loro preparazione ed uso
IT1130489B (it) Derivati chinonici particolarmente utili come medianti e procedimento per la loro preparazione
IT1123120B (it) Cefem derivati e procedimento per la loro preparazione
IT1164735B (it) Derivati adenosinici e procedimento per la loro preparazione
IT1164076B (it) Composti farmaceutici ad azione antiulcera e procedimento per la loro preparazione
IT7969010A0 (it) Derivati di benzotiepinici e procedimento per la loro preparazione
IT1165368B (it) Nuovi cefem derivati ad azione antimicrobica e procedimento per la loro preparazione
IT1147741B (it) Derivati di idrossiammino eburnano e procedimento per la loro preparazione
IT1132403B (it) Derivati di alovincamone e procedimento per la loro preparazione
IT1094902B (it) Composti bis-benzimidazolilici sostituiti,loro preparazione e loro uso
IT1143701B (it) Derivati aril-idrazonici,loro uso come pesticidi e loro preparazione
IT1135629B (it) N-imidzolil derivati di 1-cromano e procedimento per la loro preparazione
IT1132404B (it) Derivati di 10-alo-e-omoeburnano e procedimento per la loro preparazione
IT1127336B (it) Derivati della cefalosporina loro preparazione e loro impiego
IT1106130B (it) Derivati di 24-deidrovitamina d3 e loro preparazione
IT1169903B (it) Derivati epossicarbaciclinici, loro preparazione e loro uso
IT1212412B (it) Derivati della benzo-as-triazina e procedimento per la loro preparazione.
IT1174735B (it) Derivati di tunicamina di attivita antibatterica e loro metodo di preparazione
IT8303354A0 (it) Derivati carbomoil-rifamicinici,metodi per la loro preparazione e loro uso come sostanze ad azione antibatterica
IT8203626A0 (it) Nuovi derivati imidazorifamicinici, metodi per la loro preparazione e loro uso come sostanze ad azione antibatterica
IT8203360A0 (it) Nuovi derivati carbamoilrifamicinici, metodi per la loro preparazione e loro uso come sostanze ad azione antibatterica
IT1150799B (it) Cefem derivati e procedimento per la loro preparazione
IT8119566A0 (it) Derivati della prostaciclina,loro preparazione e impiego

Legal Events

Date Code Title Description
ITCP Complementary protection certificate

Free format text: CCP 46

MEDD Supplementary protection certificate for pharmaceutical products: granted

Free format text: CCP 46, 19920304; ALFA WASSERMANN S.P.A.

TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970423